These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 14569065)

  • 1. Characterization of specific opioid binding sites in neural membranes from the myenteric plexus of porcine small intestine.
    Townsend D; Portoghese PS; Brown DR
    J Pharmacol Exp Ther; 2004 Jan; 308(1):385-93. PubMed ID: 14569065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding affinity and selectivity of opioids at mu, delta and kappa receptors in monkey brain membranes.
    Emmerson PJ; Liu MR; Woods JH; Medzihradsky F
    J Pharmacol Exp Ther; 1994 Dec; 271(3):1630-7. PubMed ID: 7996478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predominance of delta-opioid-binding sites in the porcine enteric nervous system.
    Townsend D; Brown DR
    J Pharmacol Exp Ther; 2002 Mar; 300(3):900-9. PubMed ID: 11861796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional effects of systemically administered agonists and antagonists of mu, delta, and kappa opioid receptor subtypes on body temperature in mice.
    Baker AK; Meert TF
    J Pharmacol Exp Ther; 2002 Sep; 302(3):1253-64. PubMed ID: 12183687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of bivalent ligand KDN21 with heterodimeric delta-kappa opioid receptors in human embryonic kidney 293 cells.
    Xie Z; Bhushan RG; Daniels DJ; Portoghese PS
    Mol Pharmacol; 2005 Oct; 68(4):1079-86. PubMed ID: 16006595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies of micro-, kappa-, and delta-opioid receptor density and G protein activation in the cortex and thalamus of monkeys.
    Ko MC; Lee H; Harrison C; Clark MJ; Song HF; Naughton NN; Woods JH; Traynor JR
    J Pharmacol Exp Ther; 2003 Jul; 306(1):179-86. PubMed ID: 12676881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of delta opioid receptors in lung cancer using a novel nonpeptidic ligand.
    Campa MJ; Schreiber G; Bepler G; Bishop MJ; McNutt RW; Chang KJ; Patz EF
    Cancer Res; 1996 Apr; 56(7):1695-701. PubMed ID: 8603422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of opioid-binding sites in zebrafish brain.
    González-Núñez V; Barrallo A; Traynor JR; Rodríguez RE
    J Pharmacol Exp Ther; 2006 Feb; 316(2):900-4. PubMed ID: 16207834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative pharmacological properties and functional coupling of mu and delta opioid receptor sites in human neuroblastoma SH-SY5Y cells.
    Kazmi SM; Mishra RK
    Mol Pharmacol; 1987 Jul; 32(1):109-18. PubMed ID: 3037297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delta and mu opioid receptors from the brain of a urodele amphibian, the rough-skinned newt Taricha granulosa: cloning, heterologous expression, and pharmacological characterization.
    Bradford CS; Walthers EA; Stanley DJ; Baugh MM; Moore FL
    Gen Comp Endocrinol; 2006 May; 146(3):275-90. PubMed ID: 16375901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic agonist treatment converts antagonists into inverse agonists at delta-opioid receptors.
    Liu JG; Prather PL
    J Pharmacol Exp Ther; 2002 Sep; 302(3):1070-9. PubMed ID: 12183665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The stimulatory effect of mu- and delta-opioid receptors on bovine pinealocyte melatonin synthesis.
    Chuchuen U; Ebadi M; Govitrapong P
    J Pineal Res; 2004 Nov; 37(4):223-9. PubMed ID: 15485547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of specific delta-opioid binding sites in the distal small intestine of swine.
    Townsend D; Brown DR
    Eur J Pharmacol; 2003 Dec; 482(1-3):111-6. PubMed ID: 14660011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Site-directed alkylation of multiple opioid receptors. I. Binding selectivity.
    James IF; Goldstein A
    Mol Pharmacol; 1984 May; 25(3):337-42. PubMed ID: 6328259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological evidence for a 7-benzylidenenaltrexone-preferring opioid receptor mediating the inhibitory actions of peptidic delta- and mu-opioid agonists on neurogenic ion transport in porcine ileal mucosa.
    Poonyachoti S; Portoghese PS; Brown DR
    J Pharmacol Exp Ther; 2001 May; 297(2):672-9. PubMed ID: 11303057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and characterization of delta opioid binding sites in the bovine pineal.
    Aloyo VJ
    J Pharmacol Exp Ther; 1992 Jul; 262(1):292-7. PubMed ID: 1320688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of trimebutine and Jo-1196 (fedotozine) with opioid receptors in the canine ileum.
    Allescher HD; Ahmad S; Classen M; Daniel EE
    J Pharmacol Exp Ther; 1991 May; 257(2):836-42. PubMed ID: 1851839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative analysis of multiple kappa-opioid receptors by selective and nonselective ligand binding in guinea pig spinal cord: resolution of high and low affinity states of the kappa 2 receptors by a computerized model-fitting technique.
    Tiberi M; Magnan J
    Mol Pharmacol; 1990 May; 37(5):694-703. PubMed ID: 2160061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional interaction among opioid receptor types: up-regulation of mu- and delta-opioid receptor functions after repeated stimulation of kappa-opioid receptors.
    Khotib J; Narita M; Suzuki M; Yajima Y; Suzuki T
    Neuropharmacology; 2004 Mar; 46(4):531-40. PubMed ID: 14975677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel diastereomeric opioid tetrapeptides exhibit differing pharmacological activity profiles.
    Ioja E; Tourwé D; Kertész I; Tóth G; Borsodi A; Benyhe S
    Brain Res Bull; 2007 Sep; 74(1-3):119-29. PubMed ID: 17683797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.